Regen Med. 2012 Nov;7(6 Suppl):69-70. doi: 10.2217/rme.12.86.
Frank-Roman Lauter, Secretary General of the recently launched Regenerative Medicine Coalition, explains how the coalition was formed and what they hope to achieve. Frank-Roman Lauter has served as Secretary General of the Regenerative Medicine Coalition since 2012, and as Head of Business Development at Berlin-Brandenburg Center for Regenerative Therapies since 2007. Frank-Roman Lauter's interest is the organization of academic infrastructures to promote efficient translation of research findings into new therapies. He co-organizes joined strategy development for regenerative medicine clusters from seven European countries (FP7-EU Project) and has initiated cooperation between the California Institute for Regenerative Medicine and the German Federal Ministry for Education & Research, resulting in a joined funding program. Recently, he cofounded the international consortium of Regenerative Medicine translational centers (RMC; www.the-rmc.org ). Trained as a molecular biologist at the Max-Planck Institute in Berlin-Dahlem and at Stanford, he has 16 years of experience as an entrepreneur and life science manager in Germany and the USA.
雷根坦医学联盟（Regenerative Medicine Coalition）秘书长弗兰克罗曼·劳特（Frank-Roman Lauter），为我们讲述了该联盟的成立过程，以及他们希望达成的目标。自 2012 年起，弗兰克罗曼·劳特（Frank-Roman Lauter）一直担任雷根坦医学联盟（Regenerative Medicine Coalition）秘书长，并于 2007 年起担任柏林勃兰登堡再生治疗中心（Berlin-Brandenburg Center for Regenerative Therapies）业务发展主管。他的兴趣在于组织学术基础设施，以促进研究成果高效转化为新疗法。他共同组织了来自七个欧洲国家的再生医学集群联合战略发展（FP7-EU 项目），并促成了加利福尼亚再生医学研究所与德国联邦教研部之间的合作，促成了联合资助计划。最近，他共同创立了再生医学转化中心的国际联合会（RMC；www.the-rmc.org）。他在柏林达勒姆的马克斯普朗克研究所和斯坦福大学接受过分子生物学家的培训，在德国和美国拥有 16 年的创业和生命科学管理经验。
